Mei Wei, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Arvinas
    Topic:
    advisory board
    Date added:
    07/03/2024
    Date updated:
    07/03/2024
    Relationship end date:
    05/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Seagen
    Topic:
    advisory board
    Date added:
    07/03/2024
    Date updated:
    07/03/2024
    Relationship end date:
    05/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Relay therapeutics
    Topic:
    advisory board
    Date added:
    07/03/2024
    Date updated:
    07/03/2024
    Relationship end date:
    05/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astrazeneca
    Topic:
    advisory board
    Date added:
    07/03/2024
    Date updated:
    07/03/2024
    Relationship end date:
    05/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Topic:
    advisory board
    Date added:
    07/03/2024
    Date updated:
    07/03/2024
    Relationship end date:
    05/30/2024
Return to Best of Hematology and Breast Cancer 2025, Seattle